SUPER
  1. Home
  2. Stocks
  3. GVGL
  4. Peers

GVGL · GLASS & CERAMICS

GVGL against its peers Ghani Value Glass Limited

Ghani Value Glass Limited (GVGL) is set against 7 peers in the GLASS & CERAMICS sector. By market value it ranks 3 of 8.

GLASS & CERAMICS peers on one table

CompanyLast close (Rs)Place in the 52-week rangeMarket valuePrice per rupee earned (12 months)Fund lines
GHGL40.4979%Rs 40.5 bn5.31—
TGL177.3745%Rs 30.5 bn6.611
GVGL (this company)49.4722%Rs 7.4 bn7.39—
BGL9.1210%Rs 5.8 bn——
FRCL101.4176%Rs 3.8 bn19.24—
STCL10.1023%Rs 2.4 bn——
KCL160.0052%Rs 2.3 bn——
GGGL7.7214%Rs 1.9 bn12.87—

Place in the range: 0% is the 52-week low and 100% the high, on closes adjusted for splits and bonus issues. The other companies are those in the same PSX sector that traded in the last 10 sessions. A sector median needs 1 or more companies. As of 13 Nov 2026.

Fund lines: the number of funds that list the company in the top ten of their latest monthly report. A blank means no report shows it, not that no fund owns it.

Returns against the index and the sector

GVGL return with dividends by window

1 month3 months6 monthsSince 1 January1 year3 years5 years-1.0%-7.7%-5.9%-17.5%-11.9%50.3%61.3%KSE-100
Return with dividends, not reinvested, over each window; the KSE-100 tick reinvests dividends too. Source: PSX closes, as of 13 Nov 2026.
WindowGVGL priceGVGL with dividendsKSE-100Sector median
1 month-3.00%-1.04%+7.53%+6.56%7 companies
3 months-9.56%-7.73%-1.24%-7.59%7 companies
6 months-7.76%-5.90%+7.41%+9.91%7 companies
Since 1 January-19.13%-17.50%+2.19%-16.85%7 companies
1 year-13.62%-11.87%+10.72%-10.06%7 companies
3 years+36.47%+50.26%+213.90%+34.94%6 companies
5 years+38.98%+61.34%+288.80%-5.38%7 companies

Price only: closes adjusted for bonus and rights issues, to the latest price. With dividends: adds cash dividends, not reinvested. The KSE-100 figure reinvests dividends. Source: PSX closes and payout notices.

More on GVGL

Data from PSX via SuperX, delayed and provided for information only — not investment advice. Figures may contain errors; verify with your broker before acting. As of .